Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random
about
Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials*Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review.No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects.Significant improvements in self-reported gastrointestinal tolerability, quality of life, patient satisfaction, and adherence with lopinavir/ritonavir tablet formulation compared with soft gel capsulesA randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancyLower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.Once-daily antiretroviral therapy among treatment-experienced Muslim patients fasting for the month of Ramadan.Cost-effectiveness of once-daily versus twice-daily regimens in the treatment of HIV infection in sub-Saharan Africa: a probabilistic decision model
P2860
Q27015850-DFFA9965-C866-4F12-8D1F-3956594295D5Q35186842-1D674B48-9ADA-4E2E-85AE-581FEBE1738CQ36439051-243C6805-1C22-4289-A43F-21542CF63DBEQ36926668-EE48EFB9-9138-4936-8134-6FABB074953DQ37286950-22381915-F9A2-4580-B97A-41E807593A2FQ37696578-99A932E8-6BDF-43FE-9846-04019F60988CQ38086335-689A7139-1CDC-458E-B7B7-114D31A22684Q44636815-757CAEFD-03A6-4403-9D0D-798473601839Q57990836-AF3FC86C-E664-4A9D-B3EE-9B8A25FC5404
P2860
Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antiretroviral-naïve, HIV type 1-infected subjects: 96 week final results of the random
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Short communication: Comparabl ...... ek final results of the random
@en
Short communication: Comparabl ...... ek final results of the random
@nl
type
label
Short communication: Comparabl ...... ek final results of the random
@en
Short communication: Comparabl ...... ek final results of the random
@nl
prefLabel
Short communication: Comparabl ...... ek final results of the random
@en
Short communication: Comparabl ...... ek final results of the random
@nl
P2093
P356
P1476
Short communication: Comparabl ...... ek final results of the random
@en
P2093
Barbara da Silva
Barry Bernstein
Christian Naylor
Daniel Cohen
Juan González-García
Linda Fredrick
Louis Sloan
M05-730 Study Group
Margaret Johnson
P304
P356
10.1089/AID.2009.0307
P577
2010-08-01T00:00:00Z